Richard S. Ginsberg

2.8k total citations · 1 hit paper
25 papers, 2.2k citations indexed

About

Richard S. Ginsberg is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Richard S. Ginsberg has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Richard S. Ginsberg's work include HIV Research and Treatment (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and Immunotherapy and Immune Responses (6 papers). Richard S. Ginsberg is often cited by papers focused on HIV Research and Treatment (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and Immunotherapy and Immune Responses (6 papers). Richard S. Ginsberg collaborates with scholars based in United States and Canada. Richard S. Ginsberg's co-authors include Marcel B. Bally, Pieter R. Cullis, Lawrence D. Mayer, Rob Roy MacGregor, David B. Weiner, Jean Boyer, Richard B. Ciccarelli, Kenneth E. Ugen, Mark L. Bagarazzi and Christine E. Swenson and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Richard S. Ginsberg

25 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

1998 503 citations Rob Roy MacGregor, Jean Boyer et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard S. Ginsberg United States	19	921	741	498	454	404	25	2.2k
Sunil Shaunak United Kingdom	29	1.2k 1.2×	729 1.0×	278 0.6×	562 1.2×	787 1.9×	76	3.1k
Isabel Haro Spain	23	998 1.1×	236 0.3×	167 0.3×	402 0.9×	265 0.7×	189	2.1k
Paul F. McKay United Kingdom	30	1.4k 1.5×	1.4k 1.9×	106 0.2×	348 0.8×	351 0.9×	81	3.0k
Anne‐Marie Steffan France	22	776 0.8×	327 0.4×	170 0.3×	297 0.7×	251 0.6×	44	1.9k
Bryce Chackerian United States	34	1.4k 1.5×	1.3k 1.8×	171 0.3×	1.2k 2.6×	828 2.0×	87	4.2k
Mariane B. Melo United States	27	1.2k 1.3×	1.6k 2.2×	296 0.6×	838 1.8×	163 0.4×	49	3.5k
Mohammad Reza Aghasadeghi Iran	24	711 0.8×	375 0.5×	127 0.3×	635 1.4×	361 0.9×	185	2.1k
Sagar B. Kudchodkar United States	27	773 0.8×	914 1.2×	139 0.3×	640 1.4×	550 1.4×	45	2.8k
Sudhir Pai Kasturi United States	18	1.7k 1.8×	2.3k 3.1×	99 0.2×	756 1.7×	277 0.7×	22	3.9k
Michel Vandenbranden Belgium	29	1.7k 1.8×	573 0.8×	157 0.3×	149 0.3×	240 0.6×	66	2.4k

Countries citing papers authored by Richard S. Ginsberg

Since Specialization

Citations

This map shows the geographic impact of Richard S. Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Ginsberg more than expected).

Fields of papers citing papers by Richard S. Ginsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Ginsberg. The network helps show where Richard S. Ginsberg may publish in the future.

Co-authorship network of co-authors of Richard S. Ginsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Ginsberg. A scholar is included among the top collaborators of Richard S. Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Ginsberg. Richard S. Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graham, Barney S., M. Juliana McElrath, Michael C. Keefer, et al.. (2010). Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity. PLoS ONE. 5(8). e11995–e11995. 56 indexed citations

Cattamanchi, Ashok, Christine M. Posavad, Anna Wald, et al.. (2008). Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System. Clinical and Vaccine Immunology. 15(11). 1638–1643. 46 indexed citations

MacGregor, Rob Roy, Kenneth E. Ugen, Pablo Tebas, et al.. (2005). Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral ?blips?. Vaccine. 23(17-18). 2066–2073. 35 indexed citations

Pride, Michael W., Ronald S. Black, Michael Hagen, et al.. (2004). P4-348 Evaluation of potential immunologic mechanisms in the pathogenesis of treatment-induced meningoencephalitis in Alzheimer's disease patients treated with AN1792(QS-21). Neurobiology of Aging. 25. S574–S574. 3 indexed citations

Piedra, Pedro A., Stanley G. Cron, Alan M. Jewell, et al.. (2003). Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 21(19-20). 2448–2460. 72 indexed citations

MacGregor, Rob Roy, Richard S. Ginsberg, Kenneth E. Ugen, et al.. (2002). T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS. 16(16). 2137–2143. 84 indexed citations

Boyer, Jean, Adam D. Cohen, K. E. Lacy, et al.. (2000). Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines. The Journal of Infectious Diseases. 181(2). 476–483. 123 indexed citations

Boyer, Jean, Jong Kim, Adam D. Cohen, et al.. (1999). HIV-1 DNA vaccines and chemokines. Vaccine. 17. S53–S64. 48 indexed citations

Boyer, Jean, Michael A. Chattergoon, Kenneth E. Ugen, et al.. (1999). Enhancement of Cellular Immune Response in HIV-1 Seropositive Individuals: A DNA-Based Trial. Clinical Immunology. 90(1). 100–107. 71 indexed citations

10.

MacGregor, Rob Roy, Jean Boyer, Kenneth E. Ugen, et al.. (1998). First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response. The Journal of Infectious Diseases. 178(1). 92–100. 503 indexed citations breakdown →

11.

Ugen, Kenneth E., Susan B. Nyland, Jean Boyer, et al.. (1998). DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine. 16(19). 1818–1821. 91 indexed citations

12.

Haubrich, Richard, Charles Flexner, Michael M. Lederman, et al.. (1995). A Randomized Trial of the Activity and Safety of Ro 24-7429 (Tat Antagonist) versus Nucleoside for Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 172(5). 1246–1252. 26 indexed citations

13.

Cowens, J. Wayne, Patrick J. Creaven, William R. Greco, et al.. (1993). Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).. PubMed. 53(12). 2796–802. 112 indexed citations

14.

Mayer, Lawrence D., et al.. (1990). Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1025(2). 143–151. 216 indexed citations

15.

Klemens, S P, Michael H. Cynamon, Christine E. Swenson, & Richard S. Ginsberg. (1990). Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial Agents and Chemotherapy. 34(6). 967–970. 102 indexed citations

16.

Mayer, L.D., et al.. (1989). Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemotherapy and Pharmacology. 23(2). 81–6. 104 indexed citations

17.

Mayer, Lawrence D., et al.. (1989). Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.. PubMed. 49(21). 5922–30. 316 indexed citations

18.

Ginsberg, Richard S., et al.. (1988). Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis & Rheumatism. 31(3). 414–422. 35 indexed citations

19.

Swenson, Christine E., et al.. (1988). Preparation and use of Liposomes in the Treatment of Microbial Infections. PubMed. 15(sup1). S1–S31. 66 indexed citations

20.

Ginsberg, Richard S., et al.. (1986). African sleeping sickness presenting in an American emergency department. Annals of Emergency Medicine. 15(1). 86–88. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact